Diker Management’s NGM Biopharmaceuticals NGM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-29,996
Closed -$47.7K – 40
2024
Q1
$47.7K Buy
+29,996
New +$44.5K 0.04% 36

Diker Management's NGM Position: Q2 2024 in Review

Diker Management sold out of NGM Biopharmaceuticals (NGM) in Q2 2024, closing a stake of 29,996 shares — an estimated $47.7K sold.

Diker Management first reported a position in NGM in Q1 2024 and held it in 1 quarter. The position peaked at $47.7K in Q1 2024. 0 funds tracked by Wall St. Rank hold NGM as of Q2 2024.

  • Diker Management reported no remaining NGM Biopharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Diker Management sold 29,996 NGM Biopharmaceuticals shares in Q2 2024, an estimated $47.7K.
  • Diker Management first reported a position in NGM Biopharmaceuticals in Q1 2024 and held it in 1 quarter.
  • Diker Management's NGM Biopharmaceuticals position peaked at $47.7K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held NGM Biopharmaceuticals as of Q2 2024.

Based on Diker Management's 13F filing for Q2 2024, filed 14 Aug 2024.